Using microRNAs to help repair spinal cord injuries
MicroRNA Function During Neuronal Reprogramming in Treating Spinal Cord Injury
This study is exploring how tiny molecules called microRNAs can help turn certain brain cells into working nerve cells to help heal spinal cord injuries, offering a new way to improve recovery without the issues that come with stem cell treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10885957 on NIH RePORTER |
What this research studies
This research investigates how microRNAs can be utilized to convert glial cells into functional neurons to repair spinal cord injuries. By focusing on the reprogramming of these cells, the study aims to bypass the challenges associated with stem cell therapies, such as immunorejection and ethical concerns. The approach involves understanding the molecular mechanisms behind this conversion, which could lead to innovative treatments for spinal cord injuries. Patients may benefit from advancements in regenerative medicine that restore neuronal function and improve recovery outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced spinal cord injuries and are seeking innovative treatment options.
Not a fit: Patients with spinal cord injuries that are not amenable to cellular reprogramming or those with other complicating health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve recovery from spinal cord injuries.
How similar studies have performed: Previous research has shown promise in similar approaches, particularly in converting glial cells to neurons, indicating potential for success in this novel application.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Li, Hedong — Augusta University
- Study coordinator: Li, Hedong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.